Macrophage enzyme and reduced inflammation drive brain correction of mucopolysaccharidosis IIIB by stem cell gene therapy-Reference-Cited by-同舟云学术

Macrophage enzyme and reduced inflammation drive brain correction of mucopolysaccharidosis IIIB by stem cell gene therapy

Published:2017-11-27 Issue:1 Volume:141 Page:99-116
ISSN:0006-8950
Container-title:Brain
language:en
Short-container-title:

Author:

Holley Rebecca J,Ellison Stuart M,Fil Daniel,O’Leary Claire,McDermott John,Senthivel Nishanthi,Langford-Smith Alexander W W,Wilkinson Fiona L,D’Souza Zelpha,Parker Helen,Liao Aiyin,Rowlston Samuel,Gleitz Hélène F E,Kan Shih-Hsin,Dickson Patricia I,Bigger Brian W

Funder

Action Medical Research

Publisher

Oxford University Press (OUP)

Subject

Clinical Neurology

Link

http://academic.oup.com/brain/article-pdf/141/1/99/23055156/awx311.pdf

Reference38 articles.

1. Novel approaches and mechanisms in hematopoietic stem cell gene therapy;Discov Med,2014

2. The neuron-astrocyte-microglia triad in normal brain ageing and in a model of neuroinflammation in the rat hippocampus;PLoS One,2012

3. Improved behavior and neuropathology in the mouse model of Sanfilippo type IIIB disease after adeno-associated virus-mediated gene transfer in the striatum;J Neurosci,2004